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The Lancet has rightly given attention to the goals of reducing the burden of maternal and 
childhood undernutrition,1 focussing primarily on short-term outcomes such as infant survival 
and stunting.2 However the longer-term effects on adult health of a poor start to life3 suggest a 
further perspective. Developmental effects have been traditionally viewed in the context of 
teratogens, prematurity and growth retardation. However, developmental plasticity operates 
across the entire environmental range, from undernutrition to the excessive nutritional 
environments associated with gestational diabetes or maternal obesity,4,5 leading to 
multigenerational cycles of disease.6 The design of intervention strategies needs to take 
account of these complexities. 
Realising the potential for health improvement across the life-course requires integrating 
knowledge from several disciplines. Sponsored by the Rockefeller Foundation, an 
interdisciplinary meeting, representing clinicians and public health specialists from both 
higher and lower income countries, developmental and evolutionary biologists, geneticists, 
anthropologists and economists was held in December 2006. Our starting point was the 
question: how might adopting a developmental perspective on the human life-course inform 
efforts to reduce the burden of non-communicable disease, particularly for populations in 
rapid nutritional transition? This paper summarises the conclusions from the ensuing 
dialogue. 
 
Individual variation in risk of chronic disease 
Humans now live in evolutionarily novel environments, and mismatch between our evolved 
physiological capabilities and contemporary exposures may lead to ill-health.7,8 This is 
particularly relevant to food preferences and consumption and to energy expenditure, which 
have changed greatly over several decades in affluent societies and more recently in lower 
income countries undergoing socioeconomic improvement. Substantial variations in disease 
risk exist between individuals, even in the same environment,9 as well as between 
populations.10 This may have a genetic component,11,12 but experimental work in the 1970s, 
followed by retrospective epidemiological cohort studies, has revealed additional non-genetic 
developmental contributions to risk of later disease. Whilst caution must be exercised in 
extrapolating from historical cohorts to current conditions, a wide variety of experimental, 
clinical and prospective epidemiological studies show that changes in maternal or infant 
nutrition can produce heritable effects on risk of chronic disease.13 
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Timescales of responses to environmental change  
Organisms respond to challenges over a range of timescales (Figure 1). At one extreme, rapid 
and reversible homeostatic mechanisms counter an immediate challenge. Then, stressors or 
exposures during critical developmental periods can affect growth, tissue differentiation and 
physiological set-points, influencing responses to environmental challenges for life. Such 
adaptive plasticity, mediated in part by epigenetic processes,14,15 gives advantage in 
environments which change over several generations. The fidelity of cues inducing adaptive 
plasticity might be enhanced by integrating the experience of recent generations, and new 
evidence suggests that epigenetic mechanisms may contribute to such non-genomic 
transgenerational inheritance.16,17 On a longer timescale, the genomes of populations can 
change over many generations as the result of selection or drift, and increasingly there are 
examples of responses to environmental change being integrated into the human genome.18,19 
Clinical medicine and public health have focused largely on causation and intervention at the 
short-term end of this spectrum. It is now important to consider the consequences of 
developmental plasticity acting over the intermediate timescale.20 
 
Developmental processes and longer-term outcomes 
Developmental plasticity evolved because it is adaptive, promoting Darwinian fitness by 
enhancing survival and reproductive success.21 Plasticity uses environmental cues, which in 
mammals are transduced and buffered by the mother, to optimise the life-course strategy for 
maximal fitness, both making the best of present conditions and being well prepared for the 
future environment.22 The hormones and nutrients crossing the placenta can be affected by the 
mother’s body composition, metabolism and longer-term lifestyle as well as by her immediate 
diet and stress levels. Thus, environmental cues affecting development provide historical 
information which offspring use to predict the future.23 
However, there are limitations to this anticipatory strategy, especially for long-lived species 
such as humans, with the result that challenges during development can induce responses 
which have short-term benefits for the mother or the fetus but then longer-term costs in terms 
of reduced fitness.24,25 When environmental conditions change markedly between conception 
and adulthood, as has happened in most present human populations, the potential for a 
substantial mismatch is especially great and this contributes to disease risk. Shift in 
environmental conditions between generations may also exceed the evolved capacity for 
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intergenerational transmission of information. Because in developed societies we now live on 
average twice as long as did our Palaeolithic ancestors, the detrimental effects of inaccurate 
predictions are more likely to be apparent. 
  
Fitness versus health 
Developmental plasticity evolved to maximize an organism’s Darwinian fitness, not 
necessarily its health, and life-course strategies operate to ensure survival to reproduce rather 
than longevity. Anthropological and clinical data support this concept. Women throughout 
hunter-gatherer societies show an inverse relationship between age at menarche and 
anticipated life span,26 and in high-income countries, lower birthweight individuals have 
earlier menarche, an effect exaggerated by prepubertal weight gain.27 Although being a small 
(but healthy) individual may not be a ‘disease’ outcome, it incurs costs, in lower reproductive 
fitness, earnings or social status28, costs which may be – biologically if not ethically – viewed 
as trade-offs for gains in survival through better match of metabolic requirements to energy 
availability. 
Manipulation of developmental cues might be used to shift the adaptive capacity of the 
organism to cope in a later environment. This is possible experimentally (for example, 
metabolic disease induced by prenatal undernutrition can be prevented by postnatal hormonal 
manipulation29), but it would be premature to recommend prenatal diets with a view to 
promoting human offspring health. The impact of multiple micronutrients on fetal growth30 
and birth outcomes31 suggests that factors other than energy and protein intake in pregnancy 
may be important. Postnatal plasticity may explain the long-term differences in outcome – 
metabolic and cognitive – for infants fed by breast versus formula.32,33  
 
Implications for human health and wellbeing 
An improved understanding of adaptive developmental plasticity has three important 
implications for public health. First, interventions to improve adult health may need to start 
early in life and to take a cross-generational perspective, challenging though this is to 
policymakers and funders. Interventions starting in adult life need to take account of 
developmental history – for example, attempts to change health behaviours in adults may be 
less effective in populations which have, through adaptive responses to past environments of 
food insecurity, developed tendencies to excessive fat storage. Secondly, it must be 
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recognized that interventions in early life aimed at essential short-term gain, such as infant 
survival, may also have longer term effects on individuals throughout their life course, and 
that such effects may not always be beneficial. Programmes aimed at increasing birth weight 
may increase the risk of later diabetes, amplified by accelerated fat gain in childhood, a 
possible consequence of universal supplementation programmes.34 Thirdly, recent drives to 
develop one uniform standard for human growth35 assume that optimal health across the life 
course will be achieved through comparable growth in a variety of settings, irrespective of 
factors such as maternal diet, body composition or physical activity. The best outcome 
measure for postnatal growth remains uncertain – Black et al36 in the recent Lancet series 
proposed stunting (height-for-age) as a better indicator of undernutrition than underweight 
(weight-for-age) but in turn this assumes that the only outcome associated with inappropriate 
undernutrition is that of impaired growth. The design of interventions to promote growth 
demands consideration of the variance of risk of later disease across the whole distribution of 
growth and size, not only that associated with shifting the population mean in what appears to 
be a healthy direction in the short term.37  
Approaches to interventions for improving maternal and child health have focused largely on 
issues of survival, in consonance with the Millennium Development Goals for reducing 
maternal and child mortality substantially by the year 2015.38 Focusing on early survival, and 
on current differentials due to poverty39 and social inequalities,40 may not capture outcomes 
that have longer term implications for adult health, life expectancy, quality of life, and 
accumulation of human capital. Further, recommendations for nutritional interventions are 
frequently based on improving birth weight, focusing on gains in stature or micronutrient 
status in the short term.41 Where longer-term follow-up data are available they confirm the 
existence of a window of opportunity for intervention in early childhood, under 24 months of 
age, and only limited benefit, or even harm, of feeding strategies thereafter.3,42  
Health is often not included in calculations of human capital other than in terms of health 
expenditure, although a healthier population is an economically more productive population. 
Estimates of the true accumulation of human capital embodied in an individual should include 
more than the conventional economic measure of educational attainment: ideally it should 
incorporate the impact of events from conception or earlier, perhaps even extending to 
measures of intergenerational accrual of biological benefit. 
Robust measures of economic benefit are required to persuade policymakers of the wisdom of 
investing in a life-course approach to health, and we arrived at two specific recommendations. 
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First, the use of linear discount rates in assessing benefit disadvantages early life 
interventions43 and has limitations when considering intergenerational equity.44 Secondly, 
while utility-based measures of disease burden such as DALYs allow comparison of 
intervention programmes,2 they fail to capture intergenerational benefit or the monetary value 
of the ensuing savings in healthcare or increases in labour productivity. More sophisticated 
composite measures of outcome are required to demonstrate the true cost-benefit ratio of early 
life interventions. 
The increasing prevalence of metabolic disease worldwide, with its enormous current and 
projected costs, challenges a wide range of disciplines to provide an explanation of the 
underlying human biology and to define the optimal ways to intervene (Table 1). Merely 
focusing on genetic predisposition or improving adult lifestyle is inadequate. Disease risk 
from mismatch is exacerbated by a relatively small change in nutritional conditions in 
societies starting from a low baseline level, and the resulting increased susceptibility to 
obesity and gestational diabetes passes risk on to the next generation. Because early growth 
and development is a time in human life when substantial biological stock is transferred to 
future generations,3,45 ignoring the processes by which this occurs risks erosion of future 
human capital in both health and economic terms. As developmental plasticity results in 
variation in human phenotype and life-course strategy, adopting a ‘one size fits all’ approach 
to intervention will fail in efficacy for a percentage of the population, and may put some 
individuals at greater risk of later poor health. 
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Figure 1. Modes of human adaptability 
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Table 1. Adaptive plasticity and human health: research agenda 
 
Basic research 
• What are the mechanisms by which early life events have long-term effects, and can the 
pathway be altered or reversed?  
• What is optimal fetal development – how can it be defined in relation to later risk? 
• What are the indicators of optimal pregnancy outcome – e.g. birth size, duration of pregnancy 
– and what levels of risk do they constitute? 
• To what extent could markers of specific nutrient status prior to or during pregnancy inform 
about the likely outcomes of the pregnancy? 
• To what extent could postnatal epigenetic markers inform about the likely life course of the 
offspring? 
• What are the postnatal windows of plasticity and therefore intervention? 
• What is the extent and mechanism of intergenerational transmission of disease risk? 
 
Operational research 
• What is the significance of developmental processes in generating the burden of disease in 
different populations? 
• What approaches are possible to intervene in individuals and in populations during different 
stages of the life course (preconception, pregnancy, lactation, childhood, adult, parent)? 
• How can developmental interventions be made context-specific, balancing prevention of 
undernutrition against the later-life consequences of rapid postnatal weight gain? 
• What level of developmental risk of later chronic disease is acceptable? 
• How can the various levels of intervention (societal to individual) be designed appropriately 
within the cultural context? 
• What are the societal costs of less than optimal development, measured with more appropriate 
models than simple discounting? 
• What are the short-term and long-term economic benefits of optimizing early-life 
development? 
• What is the cost-benefit ratio of early intervention? 
• Which interventions are most likely to be cost effective? 
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